A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

Title
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
Authors
Keywords
Cholestasis, Farnesoid X receptor, Ursodeoxycholic acid
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-03-10
DOI
10.1016/j.jhep.2020.02.033

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started